Claudia Haferlach

30.9k total citations
449 papers, 9.7k citations indexed

About

Claudia Haferlach is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Claudia Haferlach has authored 449 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 338 papers in Hematology, 225 papers in Genetics and 115 papers in Molecular Biology. Recurrent topics in Claudia Haferlach's work include Acute Myeloid Leukemia Research (282 papers), Chronic Lymphocytic Leukemia Research (114 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (112 papers). Claudia Haferlach is often cited by papers focused on Acute Myeloid Leukemia Research (282 papers), Chronic Lymphocytic Leukemia Research (114 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (112 papers). Claudia Haferlach collaborates with scholars based in Germany, United States and United Kingdom. Claudia Haferlach's co-authors include Torsten Haferlach, Wolfgang Kern, Susanne Schnittger, Frank Dicker, Ulrike Bacher, Tamara Alpermann, Alexander Kohlmann, Manja Meggendorfer, Vera Grossmann and Niroshan Nadarajah and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Claudia Haferlach

409 papers receiving 9.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Haferlach Germany 53 6.9k 4.3k 3.5k 1.6k 1.3k 449 9.7k
Claude Preudhomme France 62 9.4k 1.4× 4.4k 1.0× 5.7k 1.6× 2.4k 1.5× 1.3k 1.0× 356 13.3k
Claudia Schoch Germany 56 8.9k 1.3× 3.4k 0.8× 5.1k 1.5× 2.9k 1.8× 927 0.7× 194 11.4k
Cristina Mecucci Italy 47 5.7k 0.8× 2.5k 0.6× 4.1k 1.2× 1.8k 1.1× 1.4k 1.1× 265 9.5k
Jürgen Thiele Germany 30 6.3k 0.9× 4.9k 1.1× 3.2k 0.9× 1.1k 0.7× 609 0.5× 72 8.9k
Anna Porwit Sweden 34 4.4k 0.6× 2.6k 0.6× 2.2k 0.6× 1.3k 0.8× 1.1k 0.9× 173 7.3k
Krzysztof Mrózek United States 53 7.7k 1.1× 2.4k 0.5× 5.0k 1.4× 2.7k 1.7× 462 0.3× 174 10.2k
Peter Paschka Germany 36 4.6k 0.7× 2.0k 0.5× 3.3k 0.9× 932 0.6× 302 0.2× 93 6.3k
Dan Jones United States 51 4.6k 0.7× 4.0k 0.9× 1.7k 0.5× 941 0.6× 2.3k 1.7× 256 8.6k
H. R. Gralnick United States 21 7.9k 1.2× 2.7k 0.6× 2.8k 0.8× 2.8k 1.7× 1.2k 0.9× 34 10.6k
Thoas Fioretos Sweden 39 2.5k 0.4× 1.1k 0.3× 2.5k 0.7× 1.2k 0.7× 504 0.4× 153 5.6k

Countries citing papers authored by Claudia Haferlach

Since Specialization
Citations

This map shows the geographic impact of Claudia Haferlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Haferlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Haferlach more than expected).

Fields of papers citing papers by Claudia Haferlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Haferlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Haferlach. The network helps show where Claudia Haferlach may publish in the future.

Co-authorship network of co-authors of Claudia Haferlach

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Haferlach. A scholar is included among the top collaborators of Claudia Haferlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Haferlach. Claudia Haferlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakuma, Maki, Manja Meggendorfer, Wolfgang Kern, et al.. (2025). Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations. Leukemia. 39(12). 2872–2880.
2.
Baumgartner, Francis, Constance Baer, Stefanos A. Bamopoulos, et al.. (2023). Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022. Blood. 143(12). 1139–1156. 10 indexed citations
3.
Hoermann, Gregor, Manja Meggendorfer, Constance Baer, et al.. (2021). Whole Genome Sequencing Identifies Non-KIT Mutations and Cytogenetic Aberrations in Systemic Mastocytosis but Has Limited Sensitivity for Detection of KIT D816V. Blood. 138(Supplement 1). 1495–1495.
4.
Werf, Inge van der, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.. (2021). Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. Blood Advances. 5(17). 3254–3265. 23 indexed citations
5.
Mulet‐Lazaro, Roger, Claudia Erpelinck-Verschueren, Marije Havermans, et al.. (2021). The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops. Nature Communications. 12(1). 5679–5679. 40 indexed citations
6.
Boissel, Nicolas, et al.. (2021). Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype. Clinical Lymphoma Myeloma & Leukemia. 22(3). e199–e205. 3 indexed citations
7.
Werf, Inge van der, Anna Wojtuszkiewicz, Huilan Yao, et al.. (2021). SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. Leukemia. 35(9). 2698–2702. 8 indexed citations
8.
Wojtuszkiewicz, Anna, Inge van der Werf, Stephan Hütter, et al.. (2021). Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML. Cancers. 13(16). 3929–3929. 4 indexed citations
9.
Hershberger, Courtney E., Vera Ademà, Cassandra M Kerr, et al.. (2020). Complex landscape of alternative splicing in myeloid neoplasms. Leukemia. 35(4). 1108–1120. 37 indexed citations
10.
Baer, Constance, Wencke Walter, Anna Stengel, et al.. (2019). Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival. Blood. 134(Supplement_1). 2735–2735. 7 indexed citations
11.
12.
13.
Haferlach, Torsten, Niroshan Nadarajah, Manja Meggendorfer, Claudia Haferlach, & Wolfgang Kern. (2017). Whole Genome Sequencing in Hairy Cell Leukemia-Variant (HCL-v) and Splenic Marginal Zone Lymphoma (SMZL). Blood. 130. 4003–4003. 1 indexed citations
14.
Meggendorfer, Manja, Wencke Walter, Claudia Haferlach, Wolfgang Kern, & Torsten Haferlach. (2017). Deep Learning Algorithms Support Distinction of PV, PMF, and ET Based on Clinical and Genetic Markers. Blood. 130. 4223–4223. 3 indexed citations
15.
Kern, Wolfgang, Ulrike Bacher, Claudia Haferlach, et al.. (2016). Multiparameter Flow Cytometry Provides Independent Prognostic Information in Patients with Suspected Myelodysplastic Syndromes: A Study on 804 Patients. Cytometry Part B Clinical Cytometry.
16.
Bacher, Ulrike, Wolfgang Kern, Tamara Alpermann, et al.. (2012). Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course. Leukemia Research. 36(7). 826–831. 8 indexed citations
17.
Meggendorfer, Manja, Andreas Roller, Torsten Haferlach, et al.. (2012). SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood. 120(15). 3080–3088. 219 indexed citations
18.
Bacher, Ulrike, Torsten Haferlach, Susanne Schnittger, et al.. (2010). Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 200(2). 170–174. 6 indexed citations
19.
Akagi, Tadayuki, Seishi Ogawa, Martin Dugas, et al.. (2009). Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype. Haematologica. 94(2). 213–223. 59 indexed citations
20.
Büchner, Thomas, Wolfgang E. Berdel, Claudia Haferlach, et al.. (2008). Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group. Journal of Clinical Oncology. 27(1). 61–69. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claude Preudhomme Breakdown of academic impact, for papers by Claudia Schoch Breakdown of academic impact, for papers by Cristina Mecucci Breakdown of academic impact, for papers by Jürgen Thiele Breakdown of academic impact, for papers by Anna Porwit Breakdown of academic impact, for papers by Krzysztof Mrózek Breakdown of academic impact, for papers by Peter Paschka Breakdown of academic impact, for papers by Dan Jones Breakdown of academic impact, for papers by H. R. Gralnick Breakdown of academic impact, for papers by Thoas Fioretos
Rankless by CCL
2026